The Strategic Promise of Forward-Deployed Biomanufacturing
Military forces can reduce supply chain fragility by producing essential materials on-site using synthetic biology.
1Fragile Military Supply Chains
Modern military operations rely on vulnerable, long-distance supply chains to deliver fuel, food, and essential materials. Concentrated production facilities and reliance on adversarial suppliers create significant risks. The USS Abraham Lincoln’s recent deployment highlighted these operational readiness challenges, demonstrating that current logistics models struggle to sustain forces during prolonged, high-intensity conflicts.
2Biomanufacturing as a Solution
Biomanufacturing utilizes engineered microbes, such as yeast or bacteria, to convert simple feedstocks into valuable military materials. Unlike traditional chemical plants that are large, expensive, and rigid, biological processes offer extreme flexibility. By swapping out cellular inputs, the same hardware can produce a diverse range of fuels, chemicals, plastics, or food products.
3Expeditionary Manufacturing Potential
This technology enables expeditionary manufacturing, where production occurs closer to the front lines. Future systems could fit inside truck trailers or shipping containers, allowing forces to generate materials on demand. This approach significantly reduces the need for constant, vulnerable resupply shipments, providing a unique logistical advantage that 3D printing alone cannot achieve.
4Overcoming Past Industrial Pitfalls
Previous defense biotechnology efforts often failed due to high costs and difficulty competing with established petrochemical processes. However, forward-deployed biomanufacturing prioritizes in-theater production efficiency rather than unit economics. Because base resilience is already a Department of Defense priority, these initiatives benefit from existing political support, avoiding the skepticism that hindered earlier industrial bio-projects.
5Proven Prototype Successes
Early research programs have already demonstrated feasibility. The Naval Research Laboratory developed a portable facility inside a shipping container, while DARPA-supported projects have generated food from air, water, and energy. Additionally, Project Medusa successfully engineered microbes to stabilize sandy terrain for helipads, proving that biological solutions can address diverse, critical field requirements.
6Technical Barriers to Maturity
Current systems remain immature and require further development before field deployment. Achieving high production yields in austere environments necessitates synergistic advances in organism engineering, control systems, and hardware. Early facilities will likely still require imported feedstocks like sugar, though researchers are working toward utilizing locally available resources like waste materials or air.
7Private Sector Innovation Landscape
Numerous U.S. companies are actively developing the necessary subsystems for deployable biomanufacturing. Firms like Air Protein and Solar Foods are optimizing carbon-to-food processes, while others advance lightweight bioreactors and cell-free technologies. The primary challenge is not a lack of technology, but the absence of an integrated, end-to-end system for military use.
8Pentagon Funding and Strategy
Since 2020, the Department of Defense has invested nearly $1 billion in domestic biomanufacturing, including $60.2 million across 34 projects in the Distributed Bioindustrial Manufacturing Program. Despite this funding, efforts remain fragmented. Current support focuses on infrastructure and product development rather than creating the coordinated, platform-based capabilities required for forward-deployed expeditionary manufacturing.
9Need for System Integration
The Pentagon cannot rely on the market to spontaneously supply integrated, end-to-end biomanufacturing systems. Because non-military demand for these specific capabilities is limited, military leadership must actively assemble coalitions of private actors. Utilizing existing consortia, such as the Defense Industrial Base Consortium, could streamline intellectual property issues and facilitate necessary subsystem interoperability across contractors.
10Defining Procurement Pathways
A clear pathway from prototype to procurement is essential to prevent projects from stalling. The Office of the Under Secretary of Defense for Research and Engineering should establish a targeted program to guide technology transition. Engaging entities like U.S. Transportation Command and the Defense Logistics Agency early will ensure that developed solutions meet actual operational needs.
11Regulatory and Legal Hurdles
Regulatory regimes, such as the Toxic Substances Control Act, present potential obstacles for new biotechnologies. While these regulations primarily target commercial applications, they inevitably impact military operations. Navigating these legal landscapes is a necessary step for the Department of Defense to ensure that innovative biomanufacturing platforms can be legally and safely deployed in theater.
12Strategic Imperative for Leadership
To translate biomanufacturing potential into a strategic asset, the Pentagon must shift from funding isolated technologies to fostering a coordinated ecosystem. By aligning private sector innovation with military requirements, the department can build a resilient, flexible logistics network. This transition is vital for maintaining operational superiority in an era of contested, large-scale future conflicts.
Original article: War on the Rocks — The Strategic Promise of Forward-Deployed Biomanufacturing